samedan logo
 
 
 
spacer
home > pmps > summer 2020 > practical tips to navigate the new normal
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Practical Tips to Navigate the New Normal

The life science sector is in a period of unprecedented transformation. Pharmaceutical manufacturing and packaging businesses have responded swiftly to requirements to pivot their business, producing and packaging new drugs and devices. This is in the context of unparalleled disruption to the supply chain.

The COVID-19 pandemic has accelerated processes throughout the industry. Changes that used to take months or years now take only a few weeks as life science companies support the global effort to find effective treatments for coronavirus SARS-CoV-2.

Every major manufacturer is experiencing disruption across supply chains, driven by volatility in the supply of parts and raw materials. Packaging and labelling sectors have had to respond to an unprecedented acceleration in the pace of change. In the pharma sector, many players have pivoted their operations to join in the race to develop a vaccine or repurpose existing drugs to treat COVID-19. The need to repurpose patient information labelling rapidly to meet regulatory requirements is an immediate challenge.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Gurdip Singh is CEO of Kallik, the market- leading enterprise labelling company, and a deeply experienced practitioner and leader in life science industry transformation. He previously held senior life science industry leadership roles at CSC, then DXC Technology, and is passionate about the user experience. Over Gurdip’s career he has also worked extensively in the healthcare, life science and banking industry, giving him an insight into transferable/cross-industry best practice.
spacer
Gurdip Singh at Kallik
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Arcis Biotechnology appointments Professor Steve Howell as Non-Executive Chairman

Daresbury, UK, 24 July 2019: Arcis Biotechnology (“Arcis”), the nucleic acid sample preparation solution provider, today announced it has appointed Professor Steve Howell as Non-Executive Chairman of its Board of Directors. Steve takes over the position from Paul Foulger, who was serving as Chairman on an interim basis on behalf of the Board.
More info >>

White Papers

Backward Thinking: The Reverse Engineering of A Pressurized Metered Dose Inhaler

Development of a generic equivalent to a current marketed pressurized metered dose inhaler (pMDI) product brings immense challenges. Thorough analysis is critical to gain a comprehensive understanding of the physical attributes and pharmaceutical performance of the reference marketed product. Many factors need to be assessed, understood and combined in order to successfully develop a generic pMDI which will meet the regulatory and quality requirements as an equivalent product in the anticipated target market. Significant information about the reference marketed product can be obtained from a thorough review of published literature, specifically the Summary of Product Characteristics (SPC) and Patient Information Leaflet (PIL). Additionally, baselining the reference marketed product for pharmaceutical performance offers a working target specification for in-vitro correlation. It will ensure the smoothest possible path to commercialization and maximize return on investment. In addition, baselining of the reference marketed product is done to understand batch-to-batch variability and product performance over the stated shelf life to establish targets for critical quality attributes (CQAs), which can be applied to the generic equivalent pMDI.
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement